March 6, 2024

The U.S. Federal Trade Commission, Department of Justice (DOJ), and the Department of Health and Human Services (HHS) launched a public inquiry into private equity and other corporations’ increasing control over healthcare. A press release announcing the initiative noted the growing involvement of private equity firms and corporate owners in healthcare and suggests that this may lead to “a maximizing of profits at the expense of quality care.”

The agencies issued a Request for Information (RFI) requesting public comment on deals conducted by health systems, private payers, private equity funds and other alternative asset managers that involve healthcare providers, facilities, or ancillary products or services. The inquiry seeks to understand “how certain healthcare market transactions may increase consolidation and generate profits for firms while threatening patients’ health, workers’ safety, quality of care, and affordable healthcare for patients and taxpayers.” Comments are due by May 6.

For more information, contact Gloria Romanelli, American College of Radiology® Senior Director, Legislative and Regulatory Relations, Legal Counsel, Quality and Safety.


Related ACR News

  • ACR Highlights Imaging Payment Changes in HOPPS Final Rule

    ACR outlines key radiology updates in CMS 2026 HOPPS final rule, including payment changes and quality reporting updates effective Jan. 1.

    Read more
  • ACR Provides Input to FDA on AI Measurement and Evaluation

    ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.

    Read more
  • Radiology’s Fight Against Prior Authorization Delays

    ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.

    Read more